Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AR-102 in subjects with elevated intraocular pressure
NCT00523250Phase 2Completed
- Sponsor
- Aerie Pharmaceuticals
- Start
- Sep 2007
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AR-102 in open-angle glaucoma (OAG), ocular hypertension, sponsored by Aerie Pharmaceuticals. Started Sep 2007; status: completed.
02
Drugs
AR-102
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT00523250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00523250.